Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Benchling logo — On a mission to unlock the power of biotechnology and empowe...

Benchling

On a mission to unlock the power of biotechnology and empower our global customers to get to milestones & market faster.

Founded 2012 United States San Francisco, United States 810 employees Series F+ Total: $411.13M Biotechnology, Life Sciences

General Information

Company Name Benchling
Founded Year 2012
Location United States San Francisco, United States +4
Founders / Decision Makers
Team member
Employees 810
Industries Biotechnology, Life Sciences
Funding Stage Series F+
Social

Get notified when Benchling moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Event Participation Sep 08, 2026

Benchling is hosting a live demo and AMA on September 16, 2026 to showcase how structured reaction data can benefit scientific teams.

Feature Release Sep 01, 2026

Benchling launched new capabilities for scientists to build custom R&D apps in minutes, deploy AI agents across workflows, and leverage models for reasoning through lab problems.

New Partnership Aug 18, 2026

Benchling partnered with GXL, Arc Institute, Anthropic, BenchFlow, future.bio, and Biohub to bring together the community for the #reAgent2026 hackathon.

Product Launch Aug 14, 2026

Benchling has published BenchBench-Protocol, a new AI benchmark designed to test LLMs' ability to troubleshoot and optimize wet lab protocols.

Get alerts when Benchling shows new signals

AI Insight

Bounce Watch AI
2 months ago

Benchling is aggressively expanding its AI platform for biotech R&D, marked by the launch of Benchling Automation and a new AI Experimental Design skill that enables scientists to generate AI-ready data. A significant customer win with Bayer, migrating their antibody discovery to Benchling's platform, provides strong market validation for their ability to modernize R&D workflows. These strategic product enhancements, coupled with a key consortium partnership and ongoing hiring, signal a continued strong growth trajectory and deepening market penetration in the AI-driven biotech space.

Signal Types
Product Launch Customer Acquisition Partnership Hiring Thought Leadership
Strategic Labels
AI Platform Expansion Market Validation Ecosystem Integration
Next Move: Expansion
·
Impact: 9/10
·
Ideal For: Growth Equity — Biotech AI SaaS

About Benchling

Benchling, founded in 2012, is at the forefront of transforming the biotechnology and life sciences sectors. Headquartered in the United States, this innovative platform is redefining biotech R&D for the AI era with a mission to unlock the power of biotechnology, enabling global customers to reach milestones faster.

The company's platform serves as an AI-driven solution that integrates seamlessly into research workflows, allowing scientists to design experiments, capture structured data, and operate AI agents and models. Its impact is significant, with over 200,000 scientists from academic labs to major players like Sanofi and Moderna relying on Benchling.

Benchling's recent funding achievements include a substantial $100.00M Series F investment on 1 November 2021, backed by prominent investors Lone Pine Capital, Altimeter Capital, Franklin Templeton, and Tiger Global. Such backing underscores the platform's promise in reshaping the future of biotech R&D through data-driven and AI-enhanced solutions.

Taxonomy: R&D Acceleration, Scientific Data Management, Life Sciences Software, Experiment Design, Biopharma Research, Cloud Applications, CRISPR, CAR-T Immunotherapy, Genetic Engineering, AI-Powered Research, Workflow Automation, Biotech Innovation, Data-Driven Science

Services & Products

Predictive Models Connection
Experiment Design and Analysis
Data Management and Capture
Workflow Automation
Software and AI Integration
Custom App Development
Scientific Data Modeling

Target Customers

Scientists Biopharma Companies Research Teams R&D Departments Industrial Biotech Firms Agritech Innovators Academic Institutions

Funding Rounds & Investors (9)

View All
Funding Stage Amount Investors Lead Investors Date
Series F •••••• 4
Investor Investor Investor
•••• •••• 		01 Nov 2021
Series E •••••• 12
Investor Investor Investor Investor Investor Investor Investor Investor Investor Investor Investor
•••• •••• 		01 Apr 2021
Series D •••••• 2
Investor Investor
01 May 2020
Series C •••••• 5
Investor Investor Investor Investor Investor
01 Jul 2019
Series B •••••• 3
Investor Investor Investor
01 Jun 2018

View All 9 Funding Rounds

Latest News

View All
Reshape wants to help ‘decode nature’ by automating the ‘visual’ part of lab experiments — Techcrunch
Reshape wants to help ‘decode nature’ by automating the ‘visual’ part of lab experiments
Techcrunch Apr 09, 2024
Sanofi forms cloud partnership with Benchling — Tech
Sanofi forms cloud partnership with Benchling
Tech Jun 12, 2024

Benchling Alternatives & Competitors

View All Alternatives
Benchling vs
DNAlytics
DNAlytics Belgium

Data-driven healthcare

Grant
15 employees
Biotechnology, Data Analytics
Benchling vs
Biolevate
Biolevate

Elevate human, Automate the mundane !

Seed
35 employees
Compare Benchling vs Biolevate
Benchling vs
PipeBio
PipeBio Denmark

PipeBio (now part of Benchling) builds cloud-based bioinformatics software for biologics discovery.

Pre Seed
8 employees
Biotechnology, Health and Wellness
Compare Benchling vs PipeBio
Also compare with: Benchling vs Ozette Ozette View all alternatives

FAQ About Benchling

On a mission to unlock the power of biotechnology and empower our global customers to get to milestones & market faster.
Benchling was founded in 2012.
Benchling is headquartered in San Francisco, United States.
Benchling operates in the following industries: Biotechnology, Life Sciences.
Benchling has approximately 810 employees.
Benchling has completed 9 funding rounds, raising a total of $411.13M. The latest funding stage is Series F+.
Benchling offers: Predictive Models Connection, Experiment Design and Analysis, Data Management and Capture, Workflow Automation, Software and AI Integration, Custom App Development, Scientific Data Modeling.
Top alternatives and competitors to Benchling include DNAlytics, Biolevate, PipeBio, Sphinx Bio, Ozette. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Benchling and DNAlytics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Benchling and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy